Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia

Treatment options for older patients with acute myeloid leukemia (AML) and for patients with relapsed/refractory AML are limited, and outcomes are poor. Decitabine, a hypomethylating agent, is active in patients with myelodysplastic syndrome (MDS) and AML, but its optimal dose and schedule are unkno...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Ritchie, Ellen K., Feldman, Eric J., Christos, Paul J., Rohan, Sarah D., Lagassa, Catherine B., Ippoliti, Cindy, Scandura, Joseph M., Carlson, Karen, Roboz, Gail J.
格式: Artigo
語言:Inglês
出版: 2013
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3888021/
https://ncbi.nlm.nih.gov/pubmed/23270581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.762093
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍